Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07398846 · ClinicalTrials.gov registry record · Phase 3
Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
A Phase 3 study of Plaque, sponsored by Colgate Palmolive.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 135
- Enrollment target
- 1
- Study location
NCT07398846: Recruiting Phase 3 study of Plaque, sponsored by Colgate Palmolive.
NCT07398846 is a Phase 3 study of Plaque that is actively recruiting participants, run by Colgate Palmolive. The registered enrollment target is 135 participants, above the 95-participant average among 5 other Plaque trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07398846, a Phase 3 study of Plaque, is actively recruiting participants, sponsored by Colgate Palmolive.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 135 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the efficacy of a stannous fluoride toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
Primary Outcome
score from 0 to 3 will be assigned by the examining dentist to all scoreable surfaces
Conditions Studied
Interventions
- DRUG 0.454%Stannous fluoride toothpaste
- DRUG 0.075% Cetylpyridinium Chloride (CPC) and 0.28% zinc lactatmouthwashe
- DRUG 0.76% Sodium Monofluorophosphate (Na MFP) toothpaste
- DRUG 0.022% Sodium Fluoride mouthwash
Study Locations (1)
Florida
- Consumer Research Consulting, LLC - Melbourne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2026-01-26 |
| Est. Completion | 2026-04-20 |
| Phase | Phase 3 |
What NCT07398846 shows while recruiting
NCT07398846 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, above the 95-participant average among 5 other Plaque trials with a reported enrollment target (42% higher).
The record links to 1 condition, with Plaque appearing as the primary indexed condition, and to 4 interventions - of which 0.454%Stannous fluoride toothpaste is the first listed.
NCT07398846 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07398846 about?
NCT07398846 is a clinical study titled "Efficacy of a Stannous Fluoride Toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.". To evaluate the efficacy of a stannous fluoride toothpaste, Cetylpyridinium Chloride Mouthwash, and Battery Toothbrush Regimen in Reducing Established Dental Plaque and Gingivitis.
What is the current status of trial NCT07398846?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 135 participants. The study started on 2026-01-26. Estimated completion is 2026-04-20.
What conditions does trial NCT07398846 study?
This clinical trial studies the following conditions: Plaque.
What interventions are being tested in trial NCT07398846?
The interventions under investigation include: 0.454%Stannous fluoride toothpaste (DRUG), 0.075% Cetylpyridinium Chloride (CPC) and 0.28% zinc lactatmouthwashe (DRUG), 0.76% Sodium Monofluorophosphate (Na MFP) toothpaste (DRUG), 0.022% Sodium Fluoride mouthwash (DRUG).
Who is sponsoring clinical trial NCT07398846?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07398846 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plaque
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis.
COMPLETED · Phase 3
-
Six Week Study of Experimental Mouth Rinses: Effect on Gingivitis and Plaque
COMPLETED · Phase 1
-
A Pilot Study to Evaluate a Method for Plaque When Comparing Stannous Fluoride Toothpaste to a Regular Dentifrice
COMPLETED · NA
-
ToothWave Plaque and Gingivitis Study
COMPLETED · NA
-
ToothWave Calculus Reduction and Accumulation Prevention Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI